Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant

#6 | 2024-08-01

US20240254257A1

Chemistry; metallurgy

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

#7 | 2024-07-11

US20240228665A1

Chemistry; metallurgy

METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION

#8 | 2024-04-18

US20240124611A1

Chemistry; metallurgy

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

#9 | 2024-03-21

US20240092938A1

Chemistry; metallurgy

COMPOSITIONS FOR INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION

#10 | 2024-03-07

US20240076409A1

Chemistry; metallurgy

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

#11 | 2023-07-06

US20230212314A1

Chemistry; metallurgy

Compositions and Methods of Inhibiting MASP-2 for the Treatment of Various Thrombotic Diseases and Disorders

#12 | 2022-08-18

US20220259325A1

Chemistry; metallurgy

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

#13 | 2022-01-06

US20220002439A1

Chemistry; metallurgy

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

#14 | 2021-11-18

US20210355236A1

Chemistry; metallurgy

METHODS FOR INHIBITING FIBROSIS IN A SUBJECT IN NEED THEREOF

#15 | 2021-09-23

US20210290684A1

Human necessities

Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant

#16 | 2021-09-09

US20210275667A1

Human necessities

Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders

#17 | 2021-06-24

US20210189009A1

Chemistry; metallurgy

Methods for inhibiting angiogenesis in a subject in need thereof

#18 | 2021-02-25

US20210054099A1

Chemistry; metallurgy

Compositions for inhibiting MASP-2 dependent complement activation

#19 | 2021-02-25

US20210054098A1

Chemistry; metallurgy

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

#20 | 2020-10-08

US20200317510A1

Performing operations; transporting

Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders

#21 | 2020-08-27

US20200270125A1

Performing operations; transporting

Nucleic acids encoding antibodies specifically binding to MASP-3

#22 | 2020-05-21

US20200157245A1

Chemistry; metallurgy

Methods for treating conditions associated with MASP-2 dependent complement activation

#23 | 2020-05-21

US20200157244A1

Chemistry; metallurgy

Methods of inhibiting MASP-2-dependent complement activation in a subject suffering from catastrophic antiphospholipid syndrome

#24 | 2020-05-07

US20200140570A1

Chemistry; metallurgy

Compositions and Methods of Inhibiting MASP-2 for the Treatment of Various Thrombotic Diseases and Disorders

#25 | 2020-02-13

US20200048366A1

Chemistry; metallurgy

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

#26 | 2019-09-26

US20190292272A1

Chemistry; metallurgy

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

#27 | 2019-05-02

US20190127484A1

Chemistry; metallurgy

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

#28 | 2019-05-02

US20190125802A1

Human necessities

Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant

#29 | 2019-04-25

US20190119402A1

Chemistry; metallurgy

Compositions for inhibiting MASP-2 dependent complement activation

#30 | 2019-01-17

US20190016824A1

Chemistry; metallurgy

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

#31 | 2018-10-11

US20180291112A1

Chemistry; metallurgy

Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation

#32 | 2018-05-24

US20180140697A1

Human necessities

Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders

#33 | 2017-10-05

US20170283508A1

Chemistry; metallurgy

Methods for inhibiting angiogenesis in a subject in need thereof

#34 | 2017-09-21

US20170267781A1

Chemistry; metallurgy

Methods for treating conditions associated with MASP-2 dependent complement activation

#35 | 2017-09-07

US20170253667A1

Chemistry; metallurgy

METHODS FOR INHIBITING FIBROSIS IN A SUBJECT IN NEED THEREOF

#36 | 2017-08-17

US20170233494A1

Chemistry; metallurgy

Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation

#37 | 2017-06-15

US20170166659A1

Chemistry; metallurgy

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

#38 | 2017-06-15

US20170166658A1

Chemistry; metallurgy

Methods for treating conditions associated with MASP-2 dependent complement activation

#39 | 2017-05-18

US20170137537A1

Chemistry; metallurgy

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

#40 | 2017-03-30

US20170088632A1

Chemistry; metallurgy

Compositions for inhibiting MASP-2 dependent complement activation

#41 | 2016-01-07

US20160002349A1

Chemistry; metallurgy

Compositions for inhibiting MASP-2 dependent complement activation

#42 | 2015-08-27

US20150239985A1

Chemistry; metallurgy

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

#43 | 2015-06-18

US20150166676A1

Chemistry; metallurgy

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

#44 | 2015-06-18

US20150166675A1

Chemistry; metallurgy

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

#45 | 2015-03-05

US20150064176A1

Chemistry; metallurgy

METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION

#46 | 2014-07-24

US20140205598A1

Chemistry; metallurgy

Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation

#47 | 2013-12-26

US20130344073A1

Chemistry; metallurgy

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

#48 | 2013-10-10

US20130266560A1

Chemistry; metallurgy

Methods for treating conditions associated with MASP-2 dependent complement activation

#49 | 2012-11-08

US20120282263A1

Chemistry; metallurgy

Compositions for inhibiting MASP-2 dependent complement activation

#50 | 2012-10-11

US20120258095A1

Chemistry; metallurgy

Methods for treating conditions associated with MASP-2 dependent complement activation

#51 | 2011-12-22

US20110311549A1

Chemistry; metallurgy

Methods for treating conditions associated with MASP-2 dependent complement activation

#52 | 2011-04-21

US20110091450A1

Chemistry; metallurgy

Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation

InventorID:

476648 ⎘